# Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer

> **NCT07478731** · PHASE2 · RECRUITING · sponsor: **Hong Qiu** · enrollment: 48 (estimated)

## Conditions studied

- CRC (Colorectal Cancer)

## Interventions

- **DRUG:** SHR-1701 neoadjuvant

## Key facts

- **NCT ID:** NCT07478731
- **Lead sponsor:** Hong Qiu
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-20
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07478731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07478731, "Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07478731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*